RPS6KB1 and glioblastoma: Fingolimod also inhibits the PI3K/Akt/mTOR/p70 S6K signaling pathway, thereby reducing the migration and invasion of human glioblastoma cell lines [118], the primary cause of death in glioblastoma patients [119].